Fanconi anemia
Fanconi anemia
BIIC
BIIC
Microcytic anemia: Pathology review
Macrocytic anemia: Pathology review
Anemia: Clinical
Iron deficiency anemia
Non-hemolytic normocytic anemia: Pathology review
Anemia of chronic disease
Aplastic anemia
Sideroblastic anemia
Fanconi anemia
Megaloblastic anemia
Autoimmune hemolytic anemia
Diamond-Blackfan anemia
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Alpha-thalassemia
Beta-thalassemia
Malabsorption syndromes: Pathology review
Blood histology
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Role of Vitamin K in coagulation
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Plasma cell disorders: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Warfarin
Thrombolytics
Antiplatelet medications
Hematopoietic medications
Ribonucleotide reductase inhibitors
Microtubule inhibitors
Monoclonal antibodies
DNA alkylating medications
Antimetabolites for cancer treatment
Thymus histology
Lymph node histology
Spleen histology
Sepsis
Hemolytic disease of the newborn
Graves disease
DiGeorge syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Sickle cell disease (NORD)
Paroxysmal nocturnal hemoglobinuria
Hereditary spherocytosis
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Hemophilia
Vitamin K deficiency
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Immune thrombocytopenia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Heparin-induced thrombocytopenia
Disseminated intravascular coagulation
Antithrombin III deficiency
Protein C deficiency
Antiphospholipid syndrome
Factor V Leiden
Protein S deficiency
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Leukemoid reaction
Myelodysplastic syndromes
Polycythemia vera (NORD)
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Multiple myeloma
Waldenstrom macroglobulinemia
Monoclonal gammopathy of undetermined significance
Bacillus anthracis (Anthrax)
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Pseudomonas aeruginosa
Yersinia enterocolitica
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Yersinia pestis (Plague)
Francisella tularensis (Tularemia)
Brucella
Pasteurella multocida
Borrelia burgdorferi (Lyme disease)
Leptospira
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Coxiella burnetii (Q fever)
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 8 (Kaposi sarcoma)
Yellow fever virus
Dengue virus
West Nile virus
HIV (AIDS)
Hantavirus
Candida
Pneumocystis jirovecii (Pneumocystis pneumonia)
Cryptococcus neoformans
Babesia
Plasmodium species (Malaria)
Cryptosporidium
Toxoplasma gondii (Toxoplasmosis)
Trypanosoma brucei
Trypanosoma cruzi (Chagas disease)
Leishmania
Trichomonas vaginalis
Antimetabolites: Sulfonamides and trimethoprim
Protein synthesis inhibitors: Aminoglycosides
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Herpesvirus medications
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Azoles
Antimalarials
Key Takeaways
Fanconi anemia (FA) is an autosomal recessive disorder in which there is decreased production of red blood cells (anemia), white blood cells, and platelets due to bone marrow failure. This can cause problems with the immune system, increase the risk of infection, and can lead to bleeding problems. People with FA may also have stature, upper limb malformations, and an increased incidence of acute myeloid leukemia.